ICU Medical Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for ICU Medical stock have an average target of 182.25, with a low estimate of 178 and a high estimate of 191. The average target predicts an increase of 29.86% from the current stock price of 140.35.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$178	$182.25	$180	$191
Change	+26.83%	+29.86%	+28.26%	+36.09%

Analyst Ratings

The average analyst rating for ICU Medical stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	2	2	2	2	2	1
Buy	3	3	3	3	3	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brett Fishbin Keybanc	Keybanc	Buy Maintains $175 → $180	Buy	Maintains	$175 → $180	+28.26%	Feb 20, 2026
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $172 → $178	Buy	Maintains	$172 → $178	+26.83%	Feb 20, 2026
Brett Fishbin Keybanc	Keybanc	Buy Maintains $173 → $175	Buy	Maintains	$173 → $175	+24.69%	Nov 7, 2025
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $153 → $172	Buy	Maintains	$153 → $172	+22.56%	Nov 7, 2025
Brett Fishbin Keybanc	Keybanc	Buy Maintains $191 → $173	Buy	Maintains	$191 → $173	+23.27%	Oct 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.20B

from 2.23B

-1.54%

from 2.23B

Revenue Next Year

2.29B

from 2.20B

4.10%

from 2.20B

EPS This Year

8.20

from 0.03

27,511.49%

from 0.03

EPS Next Year

9.46

from 8.20

15.28%

from 8.20

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.32B	2.28B	2.26B	2.38B	2.23B	2.20B	2.29B
Revenue Growth	3.56%	73.21%	-0.92%	5.44%	-6.33%	-1.54%	4.10%
EPS	4.74	-3.11	-1.23	-4.83	0.03	8.20	9.46
EPS Growth	17.91%	-	-	-	-	27,511.49%	15.28%
Forward PE	-	-	-	-	-	17.11	14.84
No. Analysts	-	-	-	-	-	9	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	2.3B	2.4B
Avg	2.2B	2.3B
Low	2.1B	2.2B

Revenue Growth

Revenue Growth	2026	2027
High	3.6%	9.4%
Avg	-1.5%	4.1%
Low	-6.6%	-1.6%

EPS Forecast

EPS	2026	2027
High	8.66	10.36
Avg	8.20	9.46
Low	7.77	8.75

EPS Growth

EPS Growth	2026	2027
High	29,059.8%	26.3%
Avg	27,511.5%	15.3%
Low	26,060.2%	6.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.